Jessica Ann Walsh,
MD
Languages Spoken: English
Jessica Walsh, MD, is an Associate Professor at the University of Utah School of Medicine and George E. Wahlen Veteran Affairs Medical Center. As a Rheumatologist, her clinical interests include psoriatic diseases and spondyloarthritis. She developed and serves as the Director of the Spondyloarthritis Clinic. She is the Co-Director of the Combined Psoriatic Diseases Clinic in which psoriatic patients are jointly cared for by a rheumatologist and a dermatologist during the same clinic visit.
Walsh received her Medical Degree and Rheumatology training from the University of Utah. She is board certified in Internal Medicine and Rheumatology. She is currently a member and keynote speaker for the Spondyloarthritis Association of America and the National Psoriasis Foundation.
Clinical Locations
Rheumatology, Area E
801-581-7724
Fax: (801) 581-6069
Specialties
Board Certification and Academic Information
| Academic Departments | Internal Medicine
-
Associate Professor Dermatology - Adjunct Associate Professor |
| Academic Divisions | Rheumatology |
| Board Certification | American Board of Internal Medicine (Sub: Rheumatology) |
Patient Rating
The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Likelihood of recommending care provider
4.7/ 5
Care provider's explanation of condition/problem
4.7/ 5
Care provider's effort to include me in decisions
4.8/ 5
Wait time at clinic
4.1/ 5
Care provider's concern for questions & worries
4.7/ 5
Patient Comments
Patient comments are gathered from our Press Ganey Patient Satisfaction Survery and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
UofU Patient
October 16, 2021
UH HOSPITALS AND CLINICS
Dr. Walsh is excellent and is always attentive. She advises and listens. She remembers what you have discussed on previous visits. She is excellent.
UofU Patient
September 04, 2021
UH HOSPITALS AND CLINICS
Dr. Walsh sets the bar high for her kindness and interest in making me feel importsnt
UofU Patient
August 09, 2021
UH HOSPITALS AND CLINICS
As always - Dr Walsh is exemplary.
UofU Patient
July 25, 2021
UH HOSPITALS AND CLINICS
The doctor is very thorough. She seems to explore all treatment options. She changes my care to take advantage of all possible treatments.
UofU Patient
July 17, 2021
UH HOSPITALS AND CLINICS
I drive from Idaho to my appointments. Dr. Walsh and I had a very good conversation about by issues and discussed a plan to figure it out
UofU Patient
May 31, 2021
UH HOSPITALS AND CLINICS
Dr. Walsh defines the ideal physician. I am so fortunate to have had her as my rheumatologist since 2018. She sees the whole picture. She listens to my concerns, makes excellent care recommendations and my arthritic condition is so much better because of her direction. I have total faith in her.
UofU Patient
March 07, 2021
UH HOSPITALS AND CLINICS
excellent Doctor Who answered all questions.
UofU Patient
February 28, 2021
UH HOSPITALS AND CLINICS
Dr. Walsh is the best position in the industry, hands down. I am so lucky to have found her My health is improved, and actually my mind set has as well
UofU Patient
January 09, 2021
UH HOSPITALS AND CLINICS
Mentioned earlier. Visit limited to a conventional phone call
UofU Patient
December 14, 2020
UH HOSPITALS AND CLINICS
Dr. Jessica Walsh is a wonderful person. She spend time explained my questions. I am really appreciated her knowledge and her professionalism.
UofU Patient
November 30, 2020
UH HOSPITALS AND CLINICS
Great as always.
UofU Patient
November 12, 2020
UH HOSPITALS AND CLINICS
I very much appreciate these providers.
UofU Patient
November 02, 2020
UH HOSPITALS AND CLINICS
Dr. Walsh is the consummate professional. I feel very fortunate to have her as my doctor.
UofU Patient
October 07, 2020
UH HOSPITALS AND CLINICS
Doctor Walsh is simply the best in the business. Her knowledge, skills and expertise has saved the day for me on so many levels. I was on a biologic for my PsA, and when I retired, I lost the Enbrel that has been helping me for over 19 years. Dr. Walsh found that Remicade would be paid for by Medicare and I am doing so well.
UofU Patient
October 05, 2020
UH HOSPITALS AND CLINICS
Dr Walsh is patient and decisive. I enjoy my appointments with her.
UofU Patient
September 23, 2020
UH HOSPITALS AND CLINICS
Dr Walsh is EXCELLENT
UofU Patient
September 22, 2020
UH HOSPITALS AND CLINICS
Dr. Walsh is a sincere professional. I always feel she is concerned about my condition.
UofU Patient
September 01, 2020
UH HOSPITALS AND CLINICS
Absolutely exceptional. The doctor spent an extended period of time with me going through all my questions without ever seeming rushed or bothered. Very rare to meet a doctor with such an exceptional patience and respect for her patients.
UofU Patient
August 11, 2020
UH HOSPITALS AND CLINICS
Love Dr Walsh!
UofU Patient
August 09, 2020
UH HOSPITALS AND CLINICS
Anyone who has a problem with Doctor Walsh is crazy
UofU Patient
August 07, 2020
UH HOSPITALS AND CLINICS
I went in for a fresh discussion of my symptoms and she relied heavily on the tests from the previous doctor I went to. Doctor appointment was discussed at length only on previous tests. we didn't discuss osteoarthritis at all. I should have asked more on this. Doctor did prescribe pain gel which is good. In all, I wanted to know more about why I am having so much pain.
UofU Patient
July 12, 2020
UH HOSPITALS AND CLINICS
I am not kidding. Dr. Walsh is the best. My disease, psoriatic arthritis, is scarier than heck. She takes the time to listen to my symptoms, make suggestions and explain the myriad of lab work I have to have done. Whenever I visit with her, I feel like I am the only patient in the world, even when I know that is not true
UofU Patient
June 22, 2020
UH HOSPITALS AND CLINICS
good listener
UofU Patient
June 22, 2020
UH HOSPITALS AND CLINICS
great experience if you like the virtual world
UofU Patient
May 24, 2020
UH HOSPITALS AND CLINICS
outstanding providers. I was very impressed. Dr. Walsh and her fellow were extraordinary, caring, detail oriented, attentive. true experts. wow!!!
UofU Patient
April 06, 2020
UH HOSPITALS AND CLINICS
Poor care. Doesn't know what's going on.
UofU Patient
March 23, 2020
UH HOSPITALS AND CLINICS
very professional and knowledgeable!
UofU Patient
February 13, 2020
UH HOSPITALS AND CLINICS
I get great care from Dr. Walsh
UofU Patient
January 27, 2020
UH HOSPITALS AND CLINICS
very nice
UofU Patient
January 20, 2020
UH HOSPITALS AND CLINICS
dr. Walsh is simply the best in the business. She listens, she discusses, she gets clear and concise information, and I completely trust her skills. I have a rather complex situation, and she navigates all the possibilities with ease and professionalism. Plus, she is cheerful, friendly and no one has a better bedside manner than Jessica Walsh!
UofU Patient
December 15, 2019
UH HOSPITALS AND CLINICS
Dr. Walsh is excellent with her Patients. She appears to care very much about the welfare and health of those she treats. Could not expect more from any physician. She is a credit to her profession.
Jessica Walsh, MD, is an Associate Professor at the University of Utah School of Medicine and George E. Wahlen Veteran Affairs Medical Center. As a Rheumatologist, her clinical interests include psoriatic diseases and spondyloarthritis. She developed and serves as the Director of the Spondyloarthritis Clinic. She is the Co-Director of the Combined Psoriatic Diseases Clinic in which psoriatic patients are jointly cared for by a rheumatologist and a dermatologist during the same clinic visit.
Walsh received her Medical Degree and Rheumatology training from the University of Utah. She is board certified in Internal Medicine and Rheumatology. She is currently a member and keynote speaker for the Spondyloarthritis Association of America and the National Psoriasis Foundation.
Academic Locations
Research Statement
Dr. Walsh’s research interests include psoriatic diseases and spondyloarthritis. She lead the development of the Program to Understand the Longterm Outcomes of Spondyloarthritis (PULSAR). She also founded and manages the Utah Psoriasis Initiative Arthritis (UPIA) registry that is designed to study the genetics and clinical outcomes of psoriatic diseases. She participates in clinical drug trials for spondyloarthritis and psoriatic arthritis patients.
Board Certification and Academic Information
| Academic Departments | Internal Medicine
-
Associate Professor Dermatology - Adjunct Associate Professor |
| Academic Divisions | Rheumatology |
| Board Certification | American Board of Internal Medicine (Sub: Rheumatology) |
Education History
| Graduate Training | University of Utah Clinical Investigation M.S.C.I, 2015 |
| Fellowship | University of Utah School of Medicine Rheumatology Fellow, 2009 |
| Chief Resident | University of Utah School of Medicine Internal Medicine Chief Resident, 2007 |
| Residency | University of Utah School of Medicine Internal Medicine Resident, 2006 |
| Internship | University of Utah School of Medicine Internal Medicine Intern, 2004 |
| Professional Medical | University of Utah Medicine M.D., 2003 |
| Graduate Training | Boise State University Business Administration M.B.A., 2003 |
| Undergraduate | Whitman College Biology B.A., 1998 |
Selected Publications - Journal Articles
Journal Article
- Belman S, Walsh JA, Carroll C, Milliken M, Haaland B, Duffin KC, Krueger GG, Feng BJ (2021). Psoriasis Characteristics for the Early Detection of Psoriatic Arthritis. J Rheumatol, 48(10), 1559-1565.
- Ogdie A, Walsh JA, Chakravarty SD, Peterson S, Lo KH, Kim L, Li N, Hsia EC, Chan EKH, Kavanaugh A, Husni ME (2021). The effect of intravenous golimumab on health-related quality of life and work productivity in patients with active psoriatic arthritis: results of the Phase 3 GO-VIBRANT trial. Clin Rheumatol, 40(9), 3667-3677.
- Orbai AM, Reddy SM, Dennis N, Villacorta R, Peterson S, Mesana L, Chakravarty SD, Lin I, Karyekar CS, Wang Y, Pacou M, Walsh J (2021). Work absenteeism and disability associated with psoriasis and psoriatic arthritis in the USA-a retrospective study of claims data from 2009 TO 2020. (Epub ahead of print) Clin Rheumatol.
- Wan MT, Walsh JA, Craig ET, Husni ME, Scher JU, Reddy SM, Leung YY, Ogdie A (2020). A comparison of physical function instruments in psoriatic arthritis: HAQ-DI vs MDHAQ vs PROMIS10 global physical health. Rheumatology (Oxford), 60(5), 2307-2316.
- Walsh JA, Pei S, Penmetsa GK, Overbury RS, Clegg DO, Sauer BC (2020). Identifying Patients With Axial Spondyloarthritis in Large Datasets: Expanding Possibilities for Observational Research. J Rheumatol, 48(5), 685-692.
- Walsh JA, Cai Q, Lin I, Pericone CD, Chakravarty SD (2021). Treatment Persistence and Adherence Among Patients With Psoriatic Arthritis Who Initiated Targeted Immune Modulators in the US: A Retrospective Cohort Study. Adv Ther, 38(5), 2353-2364.
- Kiltz U, Wei JC, van der Heijde D, van den Bosch F, Walsh JA, Boonen A, Gensler LS, Hunter T, Carlier H, Dong Y, Li X, Bolce R, Strand V, Braun J (2020). Ixekizumab Improves Functioning and Health in the Treatment of Radiographic Axial Spondyloarthritis: Week 52 Results from 2 Pivotal Studies. J Rheumatol, 48(2), 188-197.
- Magrey MN, Danve AS, Ermann J, Walsh JA (2020). Recognizing Axial Spondyloarthritis: A Guide for Primary Care. Mayo Clin Proc, 95(11), 2499-2508.
- Walsh JA, Magrey M (2020). Clinical Manifestations and Diagnosis of Axial Spondyloarthritis. (Epub ahead of print) J Clin Rheumatol.
- Walsh JA, Magrey MN, Baraliakos X, Inui K, Weng MY, Lubrano E, van der Heijde D, Boonen A, Gensler LS, Strand V, Braun J, Hunter T, Li X, Zhu B, Len L, Marcelino Sandoval Calderon D, Kiltz U (2020). Ixekizumab Improves Functioning and Health in the Treatment of Active Non-Radiographic Axial Spondyloarthritis: 52-Week Results, COAST-X Trial. (Epub ahead of print) Arthritis Care Res (Hoboken).
- Walsh JA, Wan MT, Willinger C, Husni ME, Scher JU, Reddy SM, Ogdie A (2019). Measuring Outcomes in Psoriatic Arthritis: Comparing Routine Assessment of Patient Index Data and Psoriatic Arthritis Impact of Disease. J Rheumatol, 47(10), 1496-1505.
- Walsh JA, Cai Q, Lin I, Fitzgerald T, Pericone CD, Chakravarty SD (2020). Real-world 2-year treatment patterns among patients with psoriatic arthritis treated with injectable biologic therapies. Curr Med Res Opin, 36(7), 1245-1252.
- Overbury RS, Pei S, Breviu B, Clegg DO, Walsh JA (2020). Obstructive sleep apnea and fatigue in patients with inflammatory arthritis taking TNF-inhibitors. International Journal of Clinical Rheumatology, 15(3), 38.
- Haberman R, Perez-Chada L, Siegel E, Reginato A, Webster D, Chandran V, Walsh JA Rosen C, Reddy S, Ogdie A, Scher J, Merola J (2020). Psoriasis and Psoriatic Arthritis Clinics Multicenter Advancement Network Consortium (PPACMAN) 2018 Annual Meeting Summary. J Psoriasis Psoriatic Arthritis.
- Dougados M, Wei JC, Landew R, Sieper J, Baraliakos X, Van den Bosch F, Maksymowych WP, Ermann J, Walsh JA, Tomita T, Deodhar A, van der Heijde D, Li X, Zhao F, Bertram CC, Gallo G, Carlier H, Gensler LS, COAST-V and COAST-W Study Groups (2019). Efficacy and safety of ixekizumab through 52 weeks in two phase 3, randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST-V and COAST-W). Ann Rheum Dis, 79(2), 176-185.
- Walsh JA, Pei S, Penmetsa G, Hansen JL, Cannon GW, Clegg DO, Sauer BC (2019). Identification of Axial Spondyloarthritis Patients in a Large Dataset: The Development and Validation of Novel Methods. J Rheumatol, 47(1), 42-49.
- Deodhar A, Gensler LS, Magrey M, Walsh JA, Winseck A, Grant D, Mease PJ (2019). Assessing Physical Activity and Sleep in Axial Spondyloarthritis: Measuring the Gap. Rheumatol Ther, 6(4), 487-501.
- Walsh JA, Pei S, Penmetsa GK, Sauer BC, Patil V, Walker JH, Clewell J, Douglas KM, Clegg DO, Cannon GW, Halwani A (2019). Treatment Patterns with Disease-Modifying Antirheumatic Drugs in U.S. Veterans with Newly Diagnosed Rheumatoid Arthritis, Psoriatic Arthritis, or Ankylosing Spondylitis. J Manag Care Spec Pharm, 25(11), 1218-1228.
- Walsh J, Hunter T, Schroeder K, Sandoval D, Bolce R (2019). Trends in diagnostic prevalence and treatment patterns of male and female ankylosing spondylitis patients in the United States, 2006-2016. BMC Rheumatol, 3, 39.
- Mease P, Walsh JA, Baraliakos X, Inman R, de Vlam K, Wei JC, Hunter T, Gallo G, Sandoval D, Zhao F, Dong Y, Bolce R, Marzo-Ortega H (2019). Translating Improvements with Ixekizumab in Clinical Trial Outcomes into Clinical Practice: ASAS40, Pain, Fatigue, and Sleep in Ankylosing Spondylitis. Rheumatol Ther, 6(3), 435-450.
- Coit P, Kaushik P, Caplan L, Kerr G, Walsh JA, Dubreuil M, Reimold A, Sawalha A (2019). Genome-wide DNA methylation analysis in ankylosing spondylitis identifies HLA-B*27 dependent and independent DNA methylation changes in whole blood. J Autoimmun, 102, 126-132.
- Walsh JA, Rozycki M, Yi E, Park Y (2019). Application of machine learning in the diagnosis of axial spondyloarthritis. Curr Opin Rheumatol, 31(4), 362-367.
- Braaten TJ, Zhang C, Presson AP, Breviu B, Clegg DO, Walsh JA (2019). Gender Differences in Psoriatic Arthritis with Fatigue, Pain, Function and Work Disability. J Psoriasis Psoriatic Arthritis, 4(4), 192-197.
- Farahi JM, Lynn BS, Anand P, Smith DH, Walsh JA, Hashim M, Duong R, Dellavalle RP, Reimold A, Kerr, GS, Richards JS, Chang E, Kaushik P, Dubreuil M, Caplan L (2019). A Prospective Cross-Sectional Analysis of Construct Validity for the PALMPASS, A Brief Patient-Reported Outcome Measure for Psoriasis. J Psoriasis Psoriatic Arthritis, 4(4), 186-191.
- Walsh JA, Song X, Kim G, Park Y (3/24/2019). Counting the Costs of Ankylosing Spondylitis. Research Outreach, 2517(106), 82-85.
- Singh JA, Guyatt G, Ogdie A, Gladman DD, Deal C, Deodhar A, Dubreuil M, Dunham J, Husni ME, Kenny S, Kwan-Morley J, Lin J, Marchetta P, Mease PJ, Merola JF, Miner J, Ritchlin CT, Siaton B, Smith BJ, Van Voorhees AS, Jonsson AH, Shah AA, Sullivan N, Turgunbaev M, Coates LC, Gottlieb A, Magrey M, Nowell WB, Orbai AM, Reddy SM, Scher JU, Siegel E, Siegel M, Walsh JA, Turner AS, Reston J (2018). Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis. Arthritis Care Res (Hoboken), 71(1), 2-29.
- Singh JA, Guyatt G, Ogdie A, Gladman DD, Deal C, Deodhar A, Dubreuil M, Dunham J, Husni ME, Kenny S, Kwan-Morley J, Lin J, Marchetta P, Mease PJ, Merola JF, Miner J, Ritchlin CT, Siaton B, Smith BJ, Van Voorhees AS, Jonsson AH, Shah AA, Sullivan N, Turgunbaev M, Coates LC, Gottlieb A, Magrey M, Nowell WB, Orbai AM, Reddy SM, Scher JU, Siegel E, Siegel M, Walsh JA, Turner AS, Reston J (2018). Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis. Arthritis Rheumatol, 71(1), 5-32.
- Walsh JA, Gottlieb AB, Hoepken B, Nurminen T, Mease PJ (2018). Efficacy of certolizumab pegol with and without concomitant use of disease-modifying anti-rheumatic drugs over 4 years in psoriatic arthritis patients: results from the RAPID-PsA randomized controlled trial. Clin Rheumatol, 37(12), 3285-3296.
- Walsh JA, Song X, Kim G, Park Y (2018). Healthcare Utilization and Direct Costs in Patients with Ankylosing Spondylitis Using a Large US Administrative Claims Database. Rheumatol Ther, 5(2), 463-474.
- Walsh JA, Song X, Kim G, Park Y (2018). Evaluation of the comorbidity burden in patients with ankylosing spondylitis using a large US administrative claims data set. J Cardiol Cardiovasc Sci, 2(6), 17-23.
- Walsh JA, Jones H, Mallbris L, Duffin KC, Krueger GG, Clegg DO, Szumski A (2018). The Physician Global Assessment and Body Surface Area composite tool is a simple alternative to the Psoriasis Area and Severity Index for assessment of psoriasis: post hoc analysis from PRISTINE and PRESTA. Psoriasis (Auckl), 8, 65-74.
- Walsh JA, Pei S, Penmetsa GK, Leng J, Cannon GW, Clegg DO, Sauer BC (2018). Cohort identification of axial spondyloarthritis in a large healthcare dataset: current and future methods. BMC Musculoskelet Disord, 19(1), 317.
- Walsh JA, Adejoro O, Chastek B, Palmer JB, Hur P (2018). Treatment Patterns Among Patients with Psoriatic Arthritis Treated with a Biologic in the United States: Descriptive Analyses from an Administrative Claims Database. J Manag Care Spec Pharm, 24(7), 623-631.
- Walsh JA, Arledge T, Nurminen T, Peterson L, Stark J (2018). PGA×BSA: A Measure of Psoriasis Severity Tested in Patients with Active Psoriatic Arthritis and Treated with Certolizumab Pegol. J Rheumatol, 45(7), 922-928.
- Walsh JA, Song X, Kim G, Park Y (2018). Evaluation of the comorbidity burden in patients with ankylosing spondylitis using a large US administrative claims data set. Clin Rheumatol, 37(7), 1869-1878.
- Walsh JA, Song X, Kim G, Park Y (2018). Evaluation of the comorbidity burden in patients with ankylosing spondylitis treated with tumour necrosis factor inhibitors using a large administrative claims data set. J Pharm Health Serv Res, 9(2), 115-121.
- Nash P, Ohson K, Walsh J, Delev N, Nguyen D, Teng L, Gmez-Reino JJ, Aelion JA, ACTIVE investigators (2018). Early and sustained efficacy with apremilast monotherapy in biological-naïve patients with psoriatic arthritis: a phase IIIB, randomised controlled trial (ACTIVE). Ann Rheum Dis, 77(5), 690-698.
- Walsh JA, Adejoro O, Chastek B, Park Y (2017). Treatment patterns of biologics in US patients with ankylosing spondylitis: descriptive analyses from a claims database. Journal of Comparative Effectiveness Research, 7(4), 369-380.
- Walsh JA, Adejoro O, Chastek B, Palmer JB, Hur P (2018). Treatment Patterns Among Patients with Psoriatic Arthritis Treated with a Biologic in the United States: Descriptive Analyses from an Administrative Claims Database. J Manag Care Spec Pharm, 1-11.
- Walsh JA, Pei S, Burningham Z, Penmetsa G, Cannon GW, Clegg DO, Sauer BC (2017). Use of Disease-modifying Antirheumatic Drugs for Inflammatory Arthritis in US Veterans: Effect of Specialty Care and Geographic Distance. J Rheumatol, 45(3), 430-436.
- Walsh JA, Tan H, Valdez H, Callis Duffin K (2017). Comparative Assessment of PASI and Variations of PGA×BSA as Measures of Psoriasis Severity. J Psoriasis Psoriatic Arthritis, 2(4), 113-118.
- van der Heijde D, Dougados M, Landew R, Sieper J, Maksymowych WP, Rudwaleit M, Van den Bosch F, Braun J, Mease PJ, Kivitz AJ, Walsh J, Davies O, Bauer L, Hoepken B, Peterson L, Deodhar A (2017). Sustained efficacy, safety and patient-reported outcomes of certolizumab pegol in axial spondyloarthritis: 4-year outcomes from RAPID-axSpA. Rheumatology (Oxford), 56(9), 1498-1509.
- Walsh JA, Shao Y, Leng J, He T, Teng CC, Redd D, Treitler Zeng Q, Burningham Z, Clegg DO, Sauer BC (2017). Identifying Axial Spondyloarthritis in Electronic Medical Records of US Veterans. Arthritis Care Res (Hoboken), 69(9), 1414-1420.
- Sauer BC, Teng CC, He T, Leng J, Lu CC, Walsh JA, Shah N, Harrison DJ, Tang DH, Cannon GW (2016). Treatment patterns and annual biologic costs in US veterans with rheumatic conditions or psoriasis. J Med Econ, 19(1), 34-43.
- Jones BB, Millsop JW, Walsh JA, Krueger GG, Callis Duffin K (2015). Onset of psoriatic arthritis during ustekinumab treatment for psoriasis: a case series of seven patients. Br J Dermatol, 173(1), 272-4.
- Walsh JA, Zhou X, Clegg DO, Teng C, Cannon GW, Sauer B (2015). Mortality in American Veterans with the HLA-B27 gene. J Rheumatol, 42(4), 638-44.
- Sieper J, Landew R, Rudwaleit M, van der Heijde D, Dougados M, Mease PJ, Braun J, Deodhar A, Kivitz A, Walsh J, Hoepken B, Nurminen T, Maksymowych WP (2014). Effect of certolizumab pegol over ninety-six weeks in patients with axial spondyloarthritis: results from a phase III randomized trial. Arthritis Rheumatol, 67(3), 668-77.
- Coates LC, Walsh J, Haroon M, FitzGerald O, Aslam T, Al Balushi F, Burden AD, Burden-Teh E, Caperon AR, Cerio R, Chattopadhyay C, Chinoy H, Goodfield MJ, Kay L, Kelly S, Kirkham BW, Lovell CR, Marzo-Ortega H, McHugh N, Murphy R, Reynolds NJ, Smith CH, Stewart EJ, Warren RB, Waxman R, Wilson HE, Helliwell PS (2013). Development and testing of new candidate psoriatic arthritis screening questionnaires combining optimal questions from existing tools. Arthritis Care Res (Hoboken), 66(9), 1410-6.
- Walsh JA, McFadden ML, Morgan MD, Sawitzke AD, Duffin KC, Krueger GG, Clegg DO (2014). Work productivity loss and fatigue in psoriatic arthritis. J Rheumatol, 41(8), 1670-4.
- Boehncke WH, Qureshi A, Merola JF, Thai D, Krueger GG, Walsh J, Kim N, Gottlieb AB (2013). Diagnosing and treating psoriatic arthritis: an update. Br J Dermatol, 170(4), 772-86.
- Kinard K, Walsh JA, Penmetsa GK, Warner JE (2014). Adalimumab and Non-Arteritic Anterior Ischaemic Optic Neuropathy: A Case Report. Neuro Ophthalmol, 38(5), 272-277.
- Walsh JA, McFadden M, Woodcock J, Clegg DO, Helliwell P, Dommasch E, Gelfand JM, Krueger GG, Duffin KC (2013). Product of the Physician Global Assessment and body surface area: a simple static measure of psoriasis severity in a longitudinal cohort. J Am Acad Dermatol, 69(6), 931-7.
- Helliwell PS, FitzGerald O, Fransen J, Gladman DD, Kreuger GG, Callis-Duffin K, McHugh N, Mease PJ, Strand V, Waxman R, Azevedo VF, Beltran Ostos A, Carneiro S, Cauli A, Espinoza LR, Flynn JA, Hassan N, Healy P, Kerzberg EM, Lee YJ, Lubrano E, Marchesoni A, Marzo-Ortega H, Porru G, Moreta EG, Nash P, Raffayova H, Ranza R, Raychaudhuri SP, Roussou E, Scarpa R, Song YW, Soriano ER, Tak PP, Ujfalussy I, de Vlam K, Walsh JA (2012). The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project). Ann Rheum Dis, 72(6), 986-91.
- Walsh JA, Callis Duffin K, Krueger GG, Clegg DO (2013). Limitations in screening instruments for psoriatic arthritis: a comparison of instruments in patients with psoriasis. J Rheumatol, 40(3), 287-93.
- Zamboni WC, Houghton PJ, Hulstein JL, Kirstein M, Walsh J, Cheshire PJ, Hanna SK, Danks MK, Stewart CF (1999). Relationship between tumor extracellular fluid exposure to topotecan and tumor response in human neuroblastoma xenograft and cell lines. Cancer Chemother Pharmacol, 43(4), 269-76.